Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04928443 |
Other study ID # |
202100112B0A3 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
August 15, 2021 |
Est. completion date |
June 20, 2022 |
Study information
Verified date |
June 2021 |
Source |
Chang Gung Memorial Hospital |
Contact |
Chia-Hsieh Chang, Prof. |
Phone |
886-33281200 |
Email |
chiahchang[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Scar is an unpleasant symptom that commonly appear after orthopedic surgery, especially the
joint procedure. Due to the wide motion range, skin around joint has excessive tension that
may increase risk for wide or conspicuous scar formation of surgical wound. Noticeable scar
can negatively impact the quality of life and psychosocial development. However, scar
management is overlooked in early recovery period easily. Patients commonly start to turn
their attention to the surgical scar after the completion of rehabilitation or the resolution
of disease or unbearable symptom. It is always beyond the best period of scar treatment, 3 to
6 months after wound healing. This study is aimed to observe and evaluate the scar formation
with or without aggressive management in pediatric population within 6 months after wound
healing.
Description:
This is an observational, case-control study. Patients will be invited to participate and
allocated to scar dressing group if they plan to use scar dressing. After gaining the written
inform consent, participants will be asked to fulfill the patient diary, including the record
of scar dressing use, patient scar assessment scale and satisfaction assessment, with
parents' help. In regular group, patients are retrospectively selected by matched factors,
such as demographics data. Scar-related data, including scar pictures, vancouver scar scale
assessment and complication, are collected from medical history in both groups.